| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at Apogee Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $121.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $82.58 | $1,651,664.00 | -0.6% | - | - | |
| Jan 14, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $81.11 | $1,622,159.12 | -0.3% | +4.7% | - | |
| Dec 10, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $75.38 | $1,507,656.55 | -0.5% | -0.9% | - | |
| Dec 4, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $75.01 | $3,000,400.00 | -3.1% | -4.3% | - | |
| Nov 13, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $63.01 | $1,260,236.10 | -0.4% | +4.5% | - | |
| Mar 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 10,000 | $30.15 | $301,511.36 | -0.4% | +18.0% | +125.8% | |
| Feb 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $40.58 | $608,700.00 | -1.1% | -13.9% | +50.3% | |
| Jan 8, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $48.85 | $732,692.88 | -0.6% | -41.5% | +57.4% | |
| Dec 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $46.58 | $698,653.68 | -0.6% | -41.6% | +45.1% | |
| Nov 6, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $59.22 | $888,320.00 | -0.6% | -31.2% | -6.5% |